HughesGRVKhamashtaMA. ‘Seronegative antiphospholipid syndrome’: an update. Lupus2019; 28: 273–274.
2.
BertolacciniMLSciasciaSMurruV, et al.Prevalence of antibodies to prothrombin in solid phase (aPT) and to phosphatidylserine–prothrombin complex (aPS/PT) in patients with and without lupus anticoagulant. Thromb Haemost2013; 109: 207–213.
3.
EURORDIS – The Voice of Rare Disease Patients in Europe, https://www.eurordis.org (accessed 20 January 2020).
4.
Listening to patients with rare diseases. Lancet 2009; 373: 868.
5.
VandeborneLVan OverbeekeEDoomsM, et al.Information needs of physicians regarding the diagnosis of rare diseases: a questionnaire-based study in Belgium. Orphanet J Rare Dis2019; 14: 99–99.
6.
NettletonSWattIO’MalleyL, et al.Understanding the narratives of people who live with medically unexplained illness. Patient Educ Couns2005; 56: 205–210.
